Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia

W. S. Haddon, Donald Prough, D. Kong, P. Petrozza

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To clarify the contribution of vasoconstrictor prostaglandins to the hypoperfusion state typically following total global cerebral ischemia, 14 mongrel dogs were subjected to 11 minutes of global cerebral ischemia. They were then randomly assigned to receive either no treatment or an intravenous bolus of the calcium channel blocker nimodipine, 10 μg/kg, 15 minuts after ischemia followed by a continuous infusion of nimodipine, 1.0 μg/kg/min. Thromboxane (Tx) A2 production, as measured by cerebral venous levels of TxB2 (the stable metabolite of TxA2) increased similarly in the two groups. In contrast to previous studies, mean postischemic cerebral blood flow did not increase sufficiently in the nimodipine-treated group to achieve statistical significance. These data suggest that the improved neurological outcome associated with nimodipine treatment following global cerebral ischemia does not relate to reduced levels of the prostaglandin precursor arachidonate.

Original languageEnglish (US)
Pages (from-to)416-420
Number of pages5
JournalJournal of Neurosurgery
Volume69
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Nimodipine
Thromboxane A2
Brain Ischemia
Prostaglandins
Cerebrovascular Circulation
Calcium Channel Blockers
Vasoconstrictor Agents
Ischemia
Dogs

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia. / Haddon, W. S.; Prough, Donald; Kong, D.; Petrozza, P.

In: Journal of Neurosurgery, Vol. 69, No. 3, 1988, p. 416-420.

Research output: Contribution to journalArticle

@article{c0dfd0995acf4e28aafbc196266231d9,
title = "Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia",
abstract = "To clarify the contribution of vasoconstrictor prostaglandins to the hypoperfusion state typically following total global cerebral ischemia, 14 mongrel dogs were subjected to 11 minutes of global cerebral ischemia. They were then randomly assigned to receive either no treatment or an intravenous bolus of the calcium channel blocker nimodipine, 10 μg/kg, 15 minuts after ischemia followed by a continuous infusion of nimodipine, 1.0 μg/kg/min. Thromboxane (Tx) A2 production, as measured by cerebral venous levels of TxB2 (the stable metabolite of TxA2) increased similarly in the two groups. In contrast to previous studies, mean postischemic cerebral blood flow did not increase sufficiently in the nimodipine-treated group to achieve statistical significance. These data suggest that the improved neurological outcome associated with nimodipine treatment following global cerebral ischemia does not relate to reduced levels of the prostaglandin precursor arachidonate.",
author = "Haddon, {W. S.} and Donald Prough and D. Kong and P. Petrozza",
year = "1988",
language = "English (US)",
volume = "69",
pages = "416--420",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia

AU - Haddon, W. S.

AU - Prough, Donald

AU - Kong, D.

AU - Petrozza, P.

PY - 1988

Y1 - 1988

N2 - To clarify the contribution of vasoconstrictor prostaglandins to the hypoperfusion state typically following total global cerebral ischemia, 14 mongrel dogs were subjected to 11 minutes of global cerebral ischemia. They were then randomly assigned to receive either no treatment or an intravenous bolus of the calcium channel blocker nimodipine, 10 μg/kg, 15 minuts after ischemia followed by a continuous infusion of nimodipine, 1.0 μg/kg/min. Thromboxane (Tx) A2 production, as measured by cerebral venous levels of TxB2 (the stable metabolite of TxA2) increased similarly in the two groups. In contrast to previous studies, mean postischemic cerebral blood flow did not increase sufficiently in the nimodipine-treated group to achieve statistical significance. These data suggest that the improved neurological outcome associated with nimodipine treatment following global cerebral ischemia does not relate to reduced levels of the prostaglandin precursor arachidonate.

AB - To clarify the contribution of vasoconstrictor prostaglandins to the hypoperfusion state typically following total global cerebral ischemia, 14 mongrel dogs were subjected to 11 minutes of global cerebral ischemia. They were then randomly assigned to receive either no treatment or an intravenous bolus of the calcium channel blocker nimodipine, 10 μg/kg, 15 minuts after ischemia followed by a continuous infusion of nimodipine, 1.0 μg/kg/min. Thromboxane (Tx) A2 production, as measured by cerebral venous levels of TxB2 (the stable metabolite of TxA2) increased similarly in the two groups. In contrast to previous studies, mean postischemic cerebral blood flow did not increase sufficiently in the nimodipine-treated group to achieve statistical significance. These data suggest that the improved neurological outcome associated with nimodipine treatment following global cerebral ischemia does not relate to reduced levels of the prostaglandin precursor arachidonate.

UR - http://www.scopus.com/inward/record.url?scp=0023714359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023714359&partnerID=8YFLogxK

M3 - Article

C2 - 3404240

AN - SCOPUS:0023714359

VL - 69

SP - 416

EP - 420

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -